ACE insertion/deletion genotype affects bradykinin metabolism

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 3, 1998, Pages 373-377

  Brown, Nancy J ^a   Blais Jr , Charles ^b   Gandhi, Sanjay K ^a   Adam, Albert ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin; Angiotensin converting enzyme; Bradykinin; Human

Indexed keywords

ANGIOTENSIN; BRADYKININ;

ADULT; ALLELE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; BRADYKININ; FEMALE; GENOTYPE; HALF-LIFE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A;

EID: 0031663217     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199809000-00006     Document Type: Article

References (21)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
2. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
3. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
4. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
5. Marre M, Bernadet P, Gallois Y, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes 1994;43:384-8.
6. Ueda S, Elliot HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype DD for angiotensin-converting enzyme. Hypertension 1995;25: 1266-9.
7. Vanhoutte PM. Endothelium and control of vascular function: state of the art lecture. Hypertension 1989;13:658-67.
8. 2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol 1992;105:771-2.
9. Gandhi SJ, Gainer J, King D, Brown NJ. Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 1998;31:90-6.
10. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
11. Kohara K, Tabuchi Y, Sonanayake PD, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensin measurement: effects of protease inhibitors and sample handling procedures. Peptides 1991;12:1135-6.
12. Senananyake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994;15:919-26.
13. 9] BK: influence of enalaprilat. Am J Physiol 1996;271:H1340-7.
14. Decarie A, Drapeau G, Closset J, Couture R, Adam A. Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 1994;15: 511-8.
15. 9-BK using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 1995; 180:247-57.
16. Lachurie M-L, Azizi M, Guyene T-T, Alhenc-Gelas F, Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-42.
17. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1994;95:948-53.
18. Skidgel RA, Erdos E. Biochemistry of angiotensin I-converting enzyme. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. 56th ed. New York: Raven Press, 1993:10.1-10.
19. Chadwick IG, Kraskiewicz M, Yeo WW, Higgins KS, Jackson PR, Ramsay LE. No relation between angiotensin-converting enzyme gene polymorphism and dermal response to bradykinin in healthy subjects. Clin Sci 1996;91:617-20.
20. Furuya K, Yamaguchi E, Hirabayashi T, et al. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet 1994;343:354.
21. Emeis JJ, Tranquille N. On the role of bradykinin in secretion from vascular endothelial cells. Agents Actions 1992;38:285-91.